MEDIA PSYOPS VETS COUNTER-INTELLIGENCE
ZIKA • THE NEW YORK TIMES & PAN-GENOCIDE
Zika Virus Mystery Solved by Analysis of New York Times Propaganda Concealing Scientific Evidence Linking the Pandemic to GM Mosquitoes Loosed in Brazil
Honolulu, HI—A Harvard-trained expert in emerging diseases has charged the New York Times with covering up conflicting interests and defrauding the public while purposely neglecting the most reasonable and obvious scientific explanation for how and why the brain-damaging strain of Zika virus suddenly emerged in Brazil in 2015.
Public records unearthed by whistleblower, Dr. Leonard G. Horowitz, author of the internationally acclaimed text, Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? (Tetrahedron, 1998), evidence heavy investments in an enterprise conducting experiments gone wrong using genetically-modified mosquitoes. Discoveries incriminate NYTimes billionaire owner Carlos Slim.
“The New York Times has been caught red handed concealing the emergence of the Zika virus from an experiment conducted in Brazil in 2014 using genetically-modified (GM) mosquitoes loosed by the Oxitec Company over which financial control is leveraged by Slim’s investment bankers,” explained Dr. Horowitz.
The doctor began investigating Zika’s origin following news of the dengue fever outbreak on the Big Island where he lives. The author and filmmaker, who has been an influential voice in state and local legislative hearings regarding vaccines, learned that the State’s chief epidemiologist, Dr. Sarah Park, who Horowitz debated on PBS last year, was solicited by Oxytec agents to release GM mosquitoes without public participation in the decision. He discovered that Oxitec reported testing mutant mosquitoes as an anti-dengue experiment in Brazil.
Oxytec, web intelligence showed, is a subsidiary of Intrexon, largely funded by New York Times investors that continue to hold controlling interests in the companies that stand to profit from the Zika pandemic. According to company records, Oxytec manufactured the GM insects tested in Brazil in 2014, along with dengue vaccine partners in Oxford University’s ISIS innovations, also funded by BlackRock and Evercore Company private equity investors.
Times owner Carlos Slim is heavily invested in BlackRock, that is administered by ISIS innovations’ and Evercore officials, including Evercore’s Senior Managing Director and Chairman of Europe Investment Banking, Bernard Taylor, co-Vice Chair for the Rockefeller JPMorgan Chase bank. Oxytec’s owner, Intrexon, whose Chairman and CEO is Randal J. Kirk, also on the Board of Directors of ZIOPHARM Oncology, Inc., largely financed by BlackRock, Third Security, LLC and Morgan Stanley.
Consequently, this financial community’s jaded history must be seriously considered, including racketeering and extorting nations to submit to the enterprise’s financial and political policies, as was witnessed during the 2014 Ebola “emergency” in Liberia.
In light of the facts, circumstances, and scientific evidence at hand, loosing dengue fever and Oxitec’s GM mosquito Zika vectors must be considered a high probability and most reasonable concern until factually disproved.
Circumstantial and Scientific Evidence of Commercial Crime
In 1947, the original Zika virus was isolated from a rhesus monkey in Uganda by Rockefeller financed researchers. The Ugandan government at that time was under British control, and apparently under an Anglo-American contract with OTRAG.) The “weak Zika virus” was then deposited with the Rockefeller Foundation, although it is apparent that Oxford Univ. engaged the secret enterprise with great interest. Years later, the Zika virus was licensed by the Rockefeller Foundation to the American Type Culture Collection (ATCC) that sells germs to vaccine makers and bioweapons contractors worldwide.
Besides Oxitec, Slim’s money and Taylor’s agents funded a variety of biotech companies and products including influenza, malaria, and dengue fever vaccines, and anti-viral therapeutics involving genetically modified germs.
According to the New York Times article (Feb. 6, 2016) “How a Medical Mystery in Brazil Led Doctors to Zika,” there are only two “leading theories” explaining the frightening outbreak. Both hypotheses date Zika’s arrival in Brazil in 2014 via travelers attending the World Cup and Va’a World Sprint canoe race in Rio de Janeiro.
But Horowitz’s “third theory” is based on science, common sense, blatent NYTimes omissions, and the fact that “[i]n April 2014, the Oxitec OX513A [GM mosquito] received technical approval for commercial release in Brazil from the National Technical Commission of Biosecurity (CTNBio),” according to company advertisements.
Oxitec reported, “a large scale release programme” carried out in Jacobina, Bahia following an earlier study there that claimed a 92% Aedes aegypti population reduction in the first area of release in Pedra Branca, Brazil.
It is highly probable that the 8% of Aedes aegypti mosquitoes that survived these initial studies mated with the GM mosquitoes, causing viral mutations as warned by researchers Thavara, Tawatsin and Nagao in the journal Epidemiology and Infection (2014 Jun; 142(6): 1245-1258).
In that study, mosquito control increased cases of dengue fever (DF), and the more life threatening dengue hemorrhagic fever (DHF), in areas of high mosquito density where people had been exposed to dengue virus from earlier bites or vaccinations.
Thavara et. al., explained that more deadly virus mutations, and more severe illnesses, occurred “mainly when an individual who has acquired antibodies to one serotype is inoculated with another serotype. It was reported that mosquito control may have increased the incidence of DF and DHF due to age-dependency in manifesting these illnesses or an immunological mechanism.”
“Thavara et. al., precisely described what the world is now witnessing,” Dr. Horowitz explained. “Zika was initially reported to be a ‘weaker strain’ of the dengue virus that suddenly mutated and mysteriously emerged in Brazil after being isolated in Uganda and shipped to America. The new Zika causes never-before-seen brain damage, called microcephaly in infants. This new disease compounds the evidence and reinforces the conclusion reported by Thavara’s group; that such risky GM mosquito experiments are contraindicated in dengue exposed populations.”
The New York Times neglected this most urgent scientific intelligence, Dr. Horowitz said. “This neglect is inconsistent with Occam’s razor analysis. The simplest most obvious and scientifically sound explanation for Zika’s deadly mutation should have been known to, and reported by, the Times reporters.
This evidence of diversionary propaganda embroils Times owners, and GM mosquito vaccine enterprise investors in Oxitec. The consumer fraud in selling and concealing risky biotechnologies is a commercial crime. The deadly experiment gone awry now threatens billions of families that may birth millions of brain damaged children. The social and financial burdens from this growing pandemic are overwhelming.
Parties liable for the damages, according to Dr. Horowitz, include NYTimes major co-investors in Oxitec such as Isis Technologies, Evercore, and the BlackRock wealth management group.
Health officials internationally are urged to thoroughly consider the Thavara study, as well as Dr. Horowitz’s report on dengue fever prepared for the Hawaii County Council (viewed online at RevolutionTelevision.net).
Based on this newly acquired intelligence, dengue vaccine and GM mosquito trials should be suspended until the exploding pandemic wanes.
– end –
 The New York Times is largely controlled by Carlos Slim, who hold substantial investments in the BlackRock Group, the world’s largest money management firm with $4.7 trillion in assets. Mr. Slim’s interests in GM insects and vaccines is verified by his grant of $150 million for central American disease prevention programs in alliance with the Bill and Melinda Gates Foundation.
 Oxitec received its seed funding through Oxford University’s Isis Innovation corporate partnership in ISIS Technologies, “a university private commercial interest enterprise.” Isis Innovation spun off Oxitec with financing administered by Bernard Taylor, Evercore’s Senior Managing Director and Chairman of Europe Investment Banking, and Rockefeller JPMorgan Chase co-Vice Chair. Besides Oxitec, Taylor’s agents funded a variety of biotech companies and products including influenza, malaria and dengue fever vaccines, and anti-viral therapeutics.
 Ralph Schlosstein is President and Chief Executive Officer of Evercore, and was for almost twenty years was the President of BlackRock, the largest asset management firm in the world, with over $4.7 trillion of assets under management. Mr. Schlosstein co-founded BlackRock in 1988, was a director since the company went public in 1999, chaired BlackRock’s Management Committee, and served on its Executive Committee and its Investment Committee. JPMorgan Chase & Co. is the parent holding company of Chase(Commerical Bank) and JPMorgan(Investment Bank). John Pierpont Morgan (J.P. Morgan) founded J.P. Morgan & Co., which is the predecessor to Morgan Stanley and JPMorgan Chase. As a result of the Glass-Stegall Act of 1933, J.P. Morgan & Co. was broken up, it spun off its investment banking activities into Morgan Stanley. J.P. Morgan & Co. continued to operate as a commercial bank. However, in the 1990’s it started to rebuild its investment banking operations. In 2000, it merged with the Chase Manhattan Bank, and JPMorgan Chase was formed. . . . Today, JPMorgan Chase is the largest Bank in the world with over US$2.6 trillion in assets. Morgan Stanley continues to operate as an investment bank. John D. Rockefeller, Jr. and the Rockefeller family were the largest shareholders of Chase National Bank.  In just four years, 2011-2013, JPMorgan Chase paid $16 billion in fines, settlements and other litigation expenses. Of the $16 billion JPMorgan Chase has shelled out, about $8.5 billion were for fines and settlements resulting from illegal actions taken by bank executives, according to Richard Eskow at the Campaign for America’s Future, who cited a new report from Joshua Rosner of Graham Fisher & Co.
The U.S. Treasury’s Office of Foreign Assets Control found that JPMorgan had illegally aided dictatorships in Cuba, Sudan, Liberia and Iran, including transferring 32,000 ounces of gold bullion for an Iranian bank. Related consideration should be given to what was happening in Liberia just prior to the Ebola emergency of 2014. A dictum in medical sociology recognizes that no epidemic in history has ever evolved divorced from major socio-economic and political upheaval. Liberia, in fact, at the time of the Ebola crisis was the world’s most tumultuous and controversial country, socio-politically, economically, and commercially, related to controversial oil drilling operations off its coast. At the same time, money was in-pouring from the International Monetary Fund, due largely to the work of the country’s high-profile president, Ellen Johnson Sirleaf, the winner of the 2011 Nobel Peace Prize, and 2012 Indira Gandhi Prize for Peace, Disarmament and Development.
Ms. Sirleaf, was awarded an honorary Doctor of Law degree from Harvard University in 2011, and the African Gender Award that same year despite being openly opposed to homosexuality. She also won the 2010 Friend of the Media in Africa Award, despite gross corruption in the county persecuting journalists who expose political corruption. In 2014, Ms. Sirleaf was listed as the 70th most powerful woman in the world by Forbes magazine.
According to Wikipedia, which is widely known to be a mouthpiece for Western Intelligence, President Sirleaf offered the United States land to establishment the United States Africa Command (AFRICOM), but America refused her offer, instead using Stuttgart, Germany for the command’s headquarters.
At the same time, Sirleaf strengthened relations with the People’s Republic of China, reaffirming Liberia’s commitment to the One-China policy. In return, China contributed to Liberia’s reconstruction, building several broadcasting transmitters to extend the Liberia Broadcasting System and a new campus for the University of Liberia.
So at the same time wooing China and America, two nations vying for military and economic dominance over earth, with both superpowers cranking out increasing amounts of propaganda to justify World War III, Sirleaf encouraged peace and condemned all war-makers!
Most people who have studied history (or Dr. Horowitz’s books and films) know that at the heart of America’s military might, as well as the emerging diseases defense industry, stands the Rockefeller family, the Rockefeller Foundation, Rockefeller-directed American Public Health Association, the American Medical Association, the Rockefeller-directed JPMorgan/Chase banking cartel, and the Rockefeller-controlled ExxonMobil Energy Company.
Consequently, the presence of Rockefeller/JPMorgan/Chase financial investments in Oxitec/Intrexon GM mosquitoes central to the “Zika mystery” chillingly satisfies Occam’s razor analysis as a high probability “vector” for the disorder threatening people internationally. See Chapter 20 in: Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? Chapter Summaries. It should be known that Ugandan dictator Idi Amin’s rule, “characterized by human rights abuses, political repression, ethnic persecution, extrajudicial killings, nepotism, corruption, and gross economic mismanagement,” did not commence until 1971; and little to no official interest in viral research occurred in Uganda aside from the British-American administration of OTRAG. It is unknown how many people in Uganda and the Congo were killed during OTRAG’s viral experiments during the late 1940s. However, the number of people killed as a result of Idi Amin’s genocideal regime was estimated by international observers to range from 100,000 to 500,000. Quote from: Wikipedia.
ZIKA SCANDAL UPDATE: NEWS FROM AROUND THE WORLD
Oxytec WEB Site circa 2015:
Oxytec and FKMCD Florida Keys Mosquito Control District | FKMCD are working together to inform the community about the mosquito releases and to answer questions. If FDA agrees that releases can proceed following their review, we anticipate starting in 2015. Oxitec male mosquitoes would be released up to 3 times a week. Project results will be made available to the public
TRIALLING A NEW WAY TO FIGHT MOSQUITOS IN THE FLORIDA KEYS
TRIALLING A NEW WAY TO FIGHT MOSQUITOS IN THE FLORIDA KEYS PROTECTING AGAINST AEDES AEGYPTI MOSQUITOS GOOD RESULTS 1 Up to 99% reduction in Ae. aegypti mosquitos that …
March 2, 2016
While the Ebola and Zika viruses have important differences, the response to the Ebola epidemic demonstrated that the typical, phased approach to medical product development can be accelerated and streamlined as appropriate, for the particular health circumstance; it may be appropriate in certain emergency circumstances to accept a greater than usual degree of uncertainty and risk in order to move rapidly to clinical trials, with the goal of getting safe, effective therapies or vaccine products to patients sooner…No locally transmitted mosquito-borne Zika virus disease cases have been reported in the continental United States to date.
Examining the U.S. Public Health Response to the Zika Virus:
Luciana Borio, M.D.
Chief Scientist (Acting)
Food and Drug Administration
Department of Health and Human Services
Subcommittee on Oversight and Investigations
House Energy and Commerce Committee
U.S. House of Representatives
Examining the Public Health Response to the Zika Virus, March 2, 2016
WHO global consultation of research related to Zika virus infection 7-9 March 2016 Geneva, Switzerland
As part of the implementation of the WHO Research & Development Blueprint for action to prevent epidemics, with financial support from the Bill and Melinda Gates Foundation and the Wellcome Trust.
Preparing for the inevitable—a blueprint for research and development Dr Marie-Paule Kieny, ADG, Health Systems and Innovation Cluster (HSI), WHO
Oxford, UK, 13th April 2016 – An independent survey finds that 64 percent of American adults nationwide, and 66 percent in Florida, support the U.S. Food and Drug Administration approving the use of genetically engineered mosquitoes in areas of the United States that are vulnerable to a Zika outbreak.
JULY 29, 2016
Four cases of Zika infection in Florida are very likely to have been caused by mosquitoes there, the State Department of Health said Friday — the first documented instances of local transmission in the continental United States. “Zika is now here,” Dr. Thomas R. Frieden, the director of the Centers for Disease Control and Prevention, said at a news briefing. JULY 29, 2016
August 5, 2016
FDA Releases Final Environmental Assessment for Genetically Engineered Mosquito
The FDA has completed the environmental review for a proposed field trial to determine whether the release of Oxitec Ltd.’s genetically engineered (GE) mosquitoes (OX513A) will suppress the local Aedes aegypti mosquito population in the release area at Key Haven, Florida. After considering thousands of public comments, the FDA has published a final environmental assessment (EA) and finding of no significant impact (FONSI) that agrees with the EA’s conclusion that the proposed field trial will not have significant impacts on the environment.
Vaccines and Therapies
There are no vaccines or treatments in advanced development for Zika virus at this time. Development programs for investigational vaccines and therapies are in the very early stages and FDA is actively engaged with NIH and BARDA to help accelerate development programs. FDA stands ready to work with medical product developers to provide technical support and clarify regulatory and data requirements necessary to move products forward in development as quickly as possible
Zika Virus Diagnostic Development
Diagnostic Tests | Available Diagnostics | Support for Diagnostic Development | Zika Virus Reference Materials | LDTs & Zika Virus | Contact FDA
There are no commercially available diagnostic tests cleared by FDA for the detection of Zika virus. FDA encourages commercial diagnostic developers and researchers developing laboratory developed tests (LDTs) for Zika virus to submit an Emergency Use Authorization (EUA) request. FDA will work interactively with developers to support such requests.
FDA has rapidly granted Emergency Use Authorizations for several in vitro diagnostic (IVD) devices. See Emergency Use Authorization for information about Zika virus diagnostics available under EUA.
Page Last Updated: 08/29/2016
Biomedical Advanced Research and Development Authority
The Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response in the U.S. Department of Health and Human Services, provides an integrated, systematic approach to the development and purchase of the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. Learn More >>
BARDA’s Medical Countermeasure Response to Zika
BARDA is collaborating with partners from the Public Health Emergency Medical Countermeasures Enterprise to address medical countermeasure needs for the Zika response both domestically and globally. BARDA is working to transition medical countermeasure candidates from early development into advanced research and development and then towards FDA approval.
BARDA has developed four strategic goals to address the medical countermeasure needs for the Zika response:
Prevent Zika virus infection through new vaccines
Detect acute and previous Zika virus infections through new rapid diagnostics
Ensure a blood supply safe from Zika virus through use of screening tests for donated blood and virus inactivation in blood products
Activate our National Medical Countermeasure Response Infrastructure to help medical countermeasure developers
To implement these strategic goals, BARDA is building on existing and new partnerships and lessons learned from the H1N1 and Ebola responses.
Florida’s Zika undercount hides extent of virus’ spread, experts say
September 10, 2016 [ 8 cases weren’t reported- oh my god we have a problem of vast proportions!]
“I don’t think the message has been strong enough, in terms of ‘We have a problem,’” said Arthur Caplan, director of medical ethics for New York University Langone Medical Center.
Mara Gambineri, a spokeswoman, said the health department tracks those cases “as they are still important for us to be aware of, but the cases are not reported in our case counts. The department reports cases of Florida residents.”
Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
That means there have been at least 64 local Zika infections in Florida this year, not the 56 cases reported so far by the health department.
Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
The vast majority of infections in Florida have been imported by residents who caught the virus while traveling abroad in places where Zika is widespread. Statewide, health officials have confirmed 700 travel-related cases, including 80 pregnant women, as of Sept. 9.
After announcing on Sept. 1 that mosquitoes in three Miami Beach locations had tested positive for Zika — a first in the nation — Florida’s Department of Agriculture and Consumer Services identified only one of the places: Miami Beach Botanical Garden, which had closed three days prior. A fourth batch of mosquitoes in Miami Beach that tested positive for Zika was announced on Friday.
The agriculture department has refused to identify all locations, citing exemptions under Florida statutes governing the sharing of confidential or exempt information and investigations into the spread of the virus, said Jennifer Meale, a spokeswoman.
Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
Read more here: http://www.miamiherald.com/news/health-care/article100939277.html#storylink=cpy
Moderna gains BARDA Zika vax funding; closes $474M funding round
by Ben Adams |
Sep 7, 2016 8:05am
Moderna gains BARDA Zika vax funding; closes $474M funding round | FierceBiotech
Moderna is edging toward a total $2 billion in funding after just 5 years of life after announcing a major new funding round–which coincides with a potential $125 million BARDA grant to help fund its mRNA Zika vaccine research.
Moderna currently has around $1.4 billion in cash on its balance sheet and the potential for over $230 million of extra funds from grants funnelled through a number of charitable and government bodies, including the Bill & Melinda Gates Foundation and BARDA–the U.S. government’s emergency health department.
I am text block
Mainstream Media Hype and Concealment of Science Won’t Help Fight Zika
CEO of Honey Colony
Thanks to sloppy reporting, fear-mongering, conflicts of interest, and algorithmic decisions, Zika – a once-upon-a-time unpopular and relatively benign virus – has quickly become a rising star of menace and malformations.
In record time, the mosquito-born Zika has reportedly spread to three dozen countries, and health organizations are now predicting it may infect as many as three to four million people within a year.
Zika is being described as a global epidemic, but it’s actually the perfect cover for big business – a convenient and brilliant way to generate profits and curb overpopulation.
Thanks to Zika, governments and their investors have conveniently upped the ante on (supposed) protection by poison.
“Given the magnitude of the Zika crisis,” the WHO stated and encouraged “affected countries and their partners to boost the use of both old and new approaches to mosquito control as the most immediate line of defense.”
The Aedes aegypti strain, as it turns out, is an “aggressive daytime biting mosquito,” clever and quite “opportunistic.” “Females,” state the WHO “often use ‘sneak attacks, approaching victims from behind and biting on ankles and elbows, which likely protects them from being noticed and getting slapped.”
Consequently we are now:
- Sending rapid-response teams to fumigate the shit out of affected regions, including areas that are oftentimes impoverished.
- Increasing the spraying of poisons inside flight cabins;
- Conducting aerial spraying despite the probability of resistance and drift.
- Getting ready to deploy millions more GMO mosquitoes (thanks in part to the World Health Organization and a little known commercial enterprise centered at Oxford);
- Telling humans not to procreate (lest they give birth to babies with brain defects)
- Accelerating the race to develop a Zika vaccine. (Obama has already issued a whopping $1.3 billion to advance research.) At least 15 groups are on the case, and clinical trials are expected to commence within a year to 18 months).
The CDC is even considering reviving DDT, according to one director.
You may think you’re a global citizen, armed with knowledge, and that governments have your back; but nothing can be further from the truth.
Consider who benefits from generating diseases and death.
For instance, the WHO is privately owned. They call themselves an agency, but Bloomberg and others call them a company. In 2010 -2011, their approved budget was $4.5 billion!
“The regulatory aspects of health organizations have been captured along with the capability of protecting We The People,” explains Dr. Leonard Horowitz, an expert in emerging diseases and author of Emerging Viruses: AIDS & Ebola–Nature, Accident or Intentional? “They have been captured by what I call the ‘Military Medical Petrochemical Pharmaceutical Banking Cartel.’”
Here are 4 other factors you probably don’t know about Zika.
1. Rockefellers: From African Forest To Online Shopping Cart
Despite CNN reports, Zika is not a “relatively new” virus. Two Scotsmen, virologist George Dick and entomologist Alexander Haddow, discovered Zika almost 70 years ago in a forest near Entebbe, Uganda.
That same year, the virus was extracted from a Rhesus Monkey and deposited with the Rockefeller Foundation. Later it was licensed to the American Type Culture Collection (ATCC), a company that sells germs to vaccine makers and bioweapons contractors worldwide. Today, the Zika virus is a commodity that can be purchased for only 599 euros.
Strangely, there have been no cases of Zika with birth defects in Africa where the virus was discovered. Also, there have been no cases of microcephaly in any country affected by Zika other than Brazil, such as Colombia, which has the highest incidence of the virus after Brazil.
2. Connect the Dots: No Real Link
Despite what the media and health organizations suggest, there is no veritable link between Zika and microcephaly.
“… A causal link between Zika infection in pregnancy and microcephaly has not, and I must emphasize, has not been established,” WHO General Director Margaret Chan said in an announcement to the WHO’s executive board. She then added that “the circumstantial evidence is suggestive [of a link] and extremely worrisome.”
There are others who are much closer to Brazil, Zika’s epicenter, who are also stating that there is no correlation.
“There is no direct evidence that the virus causes microcephaly,” affirms Dr. Patricia Pestana Garcez, a neurodevelopmental expert who studies microcephaly at the Federal University of Rio de Janeiro.
Upon further examination initial reports linking Zika and Microcepahly amongst patients were inaccurate, confers Dr. Wallace Ransom, an epidemiologist who has worked for the Centers for Disease Control.
It was the Brazilian Ministry of Health that quickly linked incomplete brain development to Zika, ignoring key factors such as the chemical model for vector control. Keep in mind that the Revolving Door is alive and spinning in Latin America too. Government employees used to work for global companies that manufacture and sell poisons.
Typically, Zika causes flu-like symptoms that are often mistaken for other arbovirus infections such as dengue or chikungunya. Symptoms include low-grade fever, myalgia, headache, retro-orbital pain, conjunctivitis, and a rash – not defects and brain deformations.
Meanwhile, microcephaly, which presents in babies with abnormally small heads due to incomplete brain development, is usually caused by an attack on the fetal brain. Causes may be alcohol abuse, a heavy blow to the body, or toxic exposure to a vaccine or pesticide. Not a bug bite.
A report issued by Physicians in the Crop-Sprayed Villages notes that in December 2013, during the Zika epidemic in French Polynesia, an increase in cases of Guillain-Barré syndrome was also detected. This neurological paralysis is often linked to immune disruption generated by viruses, vaccines and/or environmental toxins.
To reiterate, as of today, there is no definitive proof that Zika is related to microcephaly. (For those scientists who are sounding the alarm because Zika is showing up in pee, blood, amniotic fluid, and semen, let’s remind ourselves that humans have been cohabitating with viruses for eons.)
3. Bugging Out: GMO Mosquitoes
The WHO remarked that Zika “appears to have changed in character.” Apparently. But exactly how did Zika’s genetic make-up magically mutate? There has been no official explanation.
Could the recent rash of microcephaly cases – reminiscent of the thalidomide scandal of the late ‘50s and ‘60s – be an experiment gone wrong?
In 2014, a British company called Oxitec, along with the University of São Paulo and Moscamed, released 15 million GMO mosquitoes in Brazil in a purported effort to rid the world of the Aedes aegypti mosquito strain, responsible for spreading Dengue–a close cousin to Zika and the most common mosquito-borne virus.
Researchers inserted a lethal gene in male mosquitoes with the hopes they would mate with wild females; their offspring would die spontaneously, soon after becoming a larvae, unless something in their environment interfered. In this case, the antibiotic tetracycline trumps the terminator gene.
I guess researchers didn’t account for the antibiotic’s prevalence in our environment, especially Brazil, and the very real possibility that it could actually increase the survival rate of the GMO mosquito. This means that a certain percentage of these modified freak mosquitoes didn’t die, but likely mated, perhaps even with other modified freak mosquitoes. (By the way, the mosquito population can be reduced with simple solutions, such as improving water supply and garbage collection systems).
Overall, depending on whom you ask, the experiment was a failure. And oops, in the process, we may have altered and mutated the Zika strain into an extremely pathogenic, neurological-destroying virus, delivered by a clever and opportunistic insect.
“Think about it,” says Horowitz, “Viral vaccines are often made from attenuated viruses. In this case, researchers may have determined that Zika (a weaker strain of dengue) would be an effective means in immunizing people against dengue.”
“If you wanted to inject an experimental weakened strain you could go to a dengue fever infected population, such as Brazil, to do this experiment,” adds Horowitz. “It’s very plausible that they’ve injected toxic genes that can go through the placenta and enter the fetus’s brain and cause degeneration of the neurology, [which then] affects the embryological development of fetuses and the malformation of the brain and cranium itself.”
You may be thinking this all sounds effin nuts but the notion of swapping out vaccine needles for mosquito bites has been entertained before. Bill and Melinda Gates, for instance, are fans of flying geo-engineered vaccines and have funded efforts to bring this to fruition.
Around the time Oxitec et al were preparing to release GMO mosquitoes, three researchers in the Journal of Epidemiology and Infection warned how inoculating humans with a dengue fever vaccine induced a higher than normal chance of inducing antibodies.
In that study, writes Horowitz, mosquito control increased cases of dengue fever (DF), as well as the more life-threatening dengue hemorrhagic fever (DHF), in areas of high-mosquito density where people had been exposed to dengue virus from earlier bites or vaccinations.
I think this is the opposite effect companies like Oxitec are officially going for, although Horowitz disagrees while evidencing the commercial network linked to Oxitec now poised to earn billions from “GMO mosquito control,” new vaccines, pesticides, and more.
“I know some of my concerns are too frightening for ‘normal’ people to consider, but genocides most often escape public perception and remedial action before its too late, courtesy of propaganda and the media. Fear and denial mechanisms in most humans make loving civilization most susceptible to being duped and depopulated.”
Ironically, even if Horowitz is wrong, GMO mosquitoes are one of the solutions being called upon to solve the Zika pandemonium.
4. Monsanto Connection: Poisonous Water
Another viable reason for the increase in birth defects in Brazil lies in the water. In June 2014, the Ministry of Health began adding a larvicide called Pyroproxyfen to reservoirs, starting in the state of Pernambuco, where the proliferation of the Aedes aegypti mosquito is very high. Pernambuco was also the first state to report incidences of microcephaly.
This pyriproxyfen poison, which was created by Sumitomo Chemical, a Monsanto subsidiary, comes with a recommendation by the WHO. On its website, Sumitomo says Sumilarv (its marketed name), “not only poses minimal risk to mammals, birds and fish,” it can also be applied to drinking water. Drink up!
But let’s make no mistake, they’re adding a growth inhibitor, which alters the development process of larva-pupa-adult, thus generating malformations in developing mosquitoes and causing their death or incapacity. Sound familiar?
“Malformations detected in thousands of children from pregnant women living in areas where the Brazilian state added pyriproxyfen to drinking water is not a coincidence,” reads a report written by Physicians in the Crop-Sprayed Towns.
The report adds, “Evolution from zygote to embryo, from embryo to fetus and from fetus to newborn, is not far from the development process of the mosquito affected by pyriproxyfenin humans, 60 percent of our active genes are identical to those of insects such as the Aedes mosquito.”
Brazil’s southernmost state Rio Grande do Sul has just suspended the use of this poison.
Doctors from the Brazilian Association for Collective Health (ABRASCO) demand that urgent epidemiological studies taking into account this causal link be carried out. But the government firmly denies any link
Depopulation, Death, and Disease
Perhaps all these factors serve as a perfect storm of defects, death and disease. According to the WHO, this Zika catastrophe, which has been grossly exaggerated, is due in part to the collapse in the late ’60s of mosquito control programs.
“As so often happens in public health, when a health threat subsides, the control program dies. Resources dwindled, … infrastructures dismantled, and fewer specialists were trained and deployed. The mosquitoes – and the diseases they transmit –roared back with a vengeance.”
But critics, such as those cited in the Physicians in the Crop-Sprayed Towns, tell a very different story. They believe that areas, such as in Brazil, have experienced the mass usage of chemical poisons for the past 40 years with no results while “epidemics, poverty, social marginalization, deforestation, and climate change” continue to multiply.
As long as we wage war on the mosquito, the poisoning will continue at the expense of our health. Malathion (toxic to humans and bees) spraying in Brazil, Chlorpyrifos (shown to affect the developing brain of fetus and newborns) in Paraguay, Pyrethroids, (banned elsewhere) in Argentina. And the list goes on
“The idea of poisoning to produce healing is literally psychopathic,” says Horowitz. “It’s insane. As is the extent that human beings have been persuaded to believe this all because the supposed gods of science have spoken.”
The new Thalidomide?
Is the real cause of the Brazilian deformed baby epidemic another case of a misused vaccine?
(England–20th February, 2016) Amidst all the confusion and uncertainty on the cause of the rise in prevalence of microcephalic babies born in Brazil, stimulated by speculation over the possible role of the Zika virus, there is one change in public health policy in Brazil that seems to have gone unexamined.
To control the rising prevalence of whooping cough the Brazilian government introduced a mandatory programme of vaccination of all women between the ages of 12 and 39 with the Tdap vaccine (GSK’s Tetanus, Diphtheria and Pertussis vaccine, Boostrix). This started in late December 2014. A recent relevant monitoring study of the vaccination of New Zealand women between 28 and 38 weeks into pregnancy with Tdap vaccine has reported that there were no adverse outcomes when Tdap was used only during that period in pregnancy.(Walls et al)
However, in a previous nation-wide campaign in Brazil against rubella, the MMR vaccine was given post partum to mothers and infants without adverse outcomes. It was later discovered that this had resulted in a small proportion of women being accidentally vaccinated during very early stages of a subsequent and unidentified pregnancy.(Soares et al).
The potential for accidental vaccination of some women in very early and unsuspected pregnancy with the Tdap vaccine in this new programme must therefore be acknowledged.
Cranial bone formation during the first trimester is subject to epigenetic regulation, and disruption of that process can result in malformation at full term. The first reports of a sudden rise in the prevalence of these microcephalic infants emerged in the late summer of 2015, whilst the first reports of Zika infection in Brazil came only in March 2015, so this was probably too late to cause cranial malformation.
There would inevitably have been a short lag period before the increase became evident. The timing of the emergence of the new outbreak of microcephaly is therefore consistent with the initial implementation of the new Tdap vaccination programme in late 2014 and early 2015, had it resulted in disruption of cranial development in some fetuses during early 2015.
Crucially, sources in Columbia, adjacent to Brazil, report that although Zika is common there now, there is no evidence of any increase in microcephaly amonst its newborn babies – and it does not use the Tdap vaccine in this way.
Whilst there is some debate as to the true scale of the reported increase in microcephaly in Brazil (Chee), and no clear evidence that this new public health policy initiative may be the cause of the current scare, the Thalidomide tragedy reminds us that this potential link should be investigated as quickly as possible.
If Zika is needlessly allowed to be blamed for the current panic, then fetuses will be needlessly aborted by women terrified by the confusion and uncertainty that is currently propagated by the health authorities and the media.
Doug Cross, FRSB
Walls T et al(2016). Infant outcomes after exposure to Tdap vaccine in pregnancy: an observational study. BMJ Open 2016;6:e009536 doi:10.1136/bmjopen-2015-009536
Soares RC et al (2011). Follow-up Study of Unknowingly Pregnant Women Vaccinated Against Rubella in Brazil, 2001–2002. J Infect Dis. (2011) 204 (suppl 2): S729-S736. doi: 10.1093/infdis/jir429
Chee Fu Yung (2016). Time for global action on Zika virus epidemic. BMJ 2016;352:i781
For more information on this topic, click HERE.